Article
SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer.
Cancer research - 15 Apr 2025
Lloyd Eloise G, Jihad Muntadher, Manansala Judhell S, Li Wenlong, Cheng Priscilla S W, Mucciolo Gianluca, Zaccaria Marta, Pinto Teles Sara, Araos Henríquez Joaquín, Harish Sneha, Brais Rebecca, Ashworth Sally, Luo Weike, Johnson Paul M, Veghini Lisa, Vallespinos Mireia, Corbo Vincenzo, Biffi Giulia
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) contains an extensive stroma that modulates response to therapy, contributing to the dismal prognosis associated with this cancer. Evidence suggests that PDAC stromal composition is shaped by mutations within malignant cells, but most previous work has focused on preclinical models driven by KrasG12D and mutant Trp53. Elucidation of the contribution of additional known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
